Article

ASCO: Cymbalta Tames Post-Chemo Pain

The antidepressant duloxetine (Cymbalta) appears to cut down on the numbness and tingling associated with taxane or platinum-based chemotherapy, according to clinical trial results.

Pain from chemotherapy-induced peripheral neuropathy and its interference with daily life fell significantly with the drug, Ellen Lavoie Smith, PhD, of the University of Michigan School of Nursing in Ann Arbor, and colleagues found.

A clinically significant 30% or greater reduction in pain scores occurred in 33% of duloxetine-treated patients compared with 17% of placebo-treated patients, they reported here at the American Society of Clinical Oncology meeting.

Read the full story: http://hcp.lv/Lv6TA7

Source: MedPage Today

Related Videos
5 KOLs are featured in this series.
5 KOLs are featured in this series.
Parth Rali, MD
1 KOL is featured in this series.
4 KOLs are featured in this series
4 KOLs are featured in this series
5 KOLs are featured in this series.
5 KOLs are featured in this series.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo